Formaderm Showcases Eastern Aesthetic Philosophy at Guangzhou Beauty Expo; H&H Biotech Files IPO Prospectus

GuangzhouMarch 14, 2023/PR Newswire/ --March 10-12, 2023, the 60th Guangzhou Beauty Expo in ChinaHeld at the Guangzhou Pazhou International Convention and Exhibition Center.Maxigen Biotech Inc. (referred to as "Maxigen Biotech") participated in the exhibition with its medical beauty brand, Fumei Deng. This is also after...After the February Beijing Beauty Expo, Fumeideng once again appeared at the industry盛会, showcasing the charm of Eastern aesthetics.

As a grand event for the beauty industry and major health, the Beauty Expo has been established until now.For 33 years, it has currently formed a layout of seven exhibitions per year in Beijing, Shanghai, Guangzhou, and Shenzhen, becoming an important barometer of China's beauty and cosmetics industry. This edition of the Beauty Expo brings together the global beauty industry chain and omnichannel resources, attracting numerous enterprises in the cosmetics and daily chemical fields to participate. Focusing on new products and discovering new technologies, it creates a brand-new international skincare feast in an innovative way, driving the entire industry’s circulation and linked development, injecting new momentum into the beauty industry.

At this exhibition, Maxigen Biotech Inc. highlighted the display of Fumedeng.Product series, including Fumeideng Tripeptide Collagen Drink andFumei Deng Series Injectable Sodium Hyaluronate Gel, through internal and external application, to create an aesthetic ecosystem and convey ""Exquisite Craftsmanship, Ultimate Elegance" Brand Philosophy.

After years of cross-disciplinary research, the R&D team of Maxigen Biotech Inc. and Da Jiang Biomedical successfully developed the industry's first collagen tripeptide, utilizing medical-grade collagen protein technology. Through mass spectrometry sequencing analysis, the product contains nine functional peptides, featuring not only a collagen structure but also key initiators with specific repair functions, offering consumers more comprehensive skincare benefits.

Among them, Fumeiden Tripeptide Collagen Drink is one of the smallest tripeptide collagen drinks on the market, featuring international patented emulsification dual-nutrition technology (double nutri), with an average particle size of only 1-3 microns, effectively enhances bioavailability, increasing absorption by 5.5 times. In addition, this product also contains high-purity small-molecule hyaluronic acid, which hydrates and nourishes the skin, helping consumers maintain a youthful appearance.

In addition, Fumeideng places great emphasis on inheriting the cultural heritage of Eastern aesthetics, utilizing its uniqueECHA™ Balanced Cross-linking Technology creates sodium hyaluronate gel fillers. This technology unravels hyaluronic acid molecular chains through a special balancing device and evenly disperses minimal doses of micron-level cross-linking agents around, resulting in uniformly cross-linked fillers with excellent viscoelasticity and extrusion force. Pharmaceutical-grade raw materials are used to ensure safety, providing seekers of beauty with a natural and healthy "age-freezing" experience.

All along,Maxigen Biotech Inc. focuses on the research, development, and production of collagen and hyaluronic acid.Adhering to the future ecological aesthetics of "scientific beauty, humanistic beauty",Core technology, centered on biopolymer materials, is applied to two major businesses: biomedical materials and medical aesthetics skincare products. Its medical aesthetics brand is Forméd.All production processes have passed the United StatesInspections certified by the FDA, ISO, and more than 20 national standards,SelfSince entering the Chinese market in 2016, it has gained widespread recognition in the industry for its high quality and safety.

In the future, Maxigen Biotech will continue to focus on the collagen field, launching new products, advanced technologies, and medical aesthetic solutions for various indications. This effort aims to enhance the company's ecosystem in the broader health and medical aesthetics anti-aging sectors, helping consumers achieve natural, harmonious, and healthy Eastern beauty, while showcasing China’s cultural confidence.

### 

About Maxigen Biotech Inc.

Maxigen Biotech Inc.Founded in Taipei in 1998, Maxigen Biotech Inc. specializes in the research, development, and production of collagen and hyaluronic acid, with core technology centered on biomacromolecular materials applied to biomedicine and medical aesthetics skincare products.

In 2019, Maxigen Biotech joined the Da Jiang Group. As an important part of the group in the field of IBD (Integrated Biological Design) for genetic medicine and healthcare, Maxigen Biotech has obtained medical-level certifications from more than 20 countries and regions, including Taiwan, China's GMP, ISO13485, and Korea's KGMP. Since 2009, it has passed FDA on-site inspections with zero deficiencies, meeting the highest international production standards.

As of now, the product has been sold to63 countries and regions, with offices set up in 10 countries, possessing 7 global S-level production factories and 12 laboratories.